Background and Objectives: Desmopressin (DDAVP) is a synthetic derivative of vasopressin with hemostatic and fibrinolytic properties that has been used during surgery in patients with bleeding disorders. Our aim was to investigate the effect of DDAVP on lung and lymph node metastatic cell colonization using a preclinical mouse mammary carcinoma model of subcutaneous tumor manipulation and surgical excision. Methods: Female BALB/c mice bearing the highly aggressive F3II mammary carcinoma were subjected to repeated manipulations of primary tumors (0.5 kg/cm2 during 2 min), followed (or not) by surgical excision. DDAVP was administered intravenously 30 min before and 24 h after each manipulation or surgery, at a dose of 2 μg/kg. At the end of ...
In this paper we demonstrate, using the C7-2-HI metastatic transplantable ductal mammary tumor, that...
Histone deacetylase (HDAC) inhibitors and tumor necrosis factor–related apoptosis-inducing ligand (T...
Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis...
Background and Objectives: Desmopressin (DDAVP) is a synthetic derivative of vasopressin with hemost...
Desmopressin (DDAVP), a synthetic peptide analog of vasopressin, is a safe antidiuretic and hemostat...
[V4Q5]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against m...
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to...
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to...
analog of vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agoni...
[V4Q5]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against m...
Recent experimental evidence suggested that the synthetic peptide desmopressin (DDAVP) interferes tu...
Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It ac...
Several years ago, we proposed the haemostatic peptide desmopressin (1-desamino-8-d-arginine vasopre...
Aim: Development of compounds with therapeutic application requires the interaction of different dis...
The synthetic vasopressin analogue, desmopressin (dDAVP), has been shown to influence membrane trans...
In this paper we demonstrate, using the C7-2-HI metastatic transplantable ductal mammary tumor, that...
Histone deacetylase (HDAC) inhibitors and tumor necrosis factor–related apoptosis-inducing ligand (T...
Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis...
Background and Objectives: Desmopressin (DDAVP) is a synthetic derivative of vasopressin with hemost...
Desmopressin (DDAVP), a synthetic peptide analog of vasopressin, is a safe antidiuretic and hemostat...
[V4Q5]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against m...
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to...
Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to...
analog of vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agoni...
[V4Q5]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against m...
Recent experimental evidence suggested that the synthetic peptide desmopressin (DDAVP) interferes tu...
Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It ac...
Several years ago, we proposed the haemostatic peptide desmopressin (1-desamino-8-d-arginine vasopre...
Aim: Development of compounds with therapeutic application requires the interaction of different dis...
The synthetic vasopressin analogue, desmopressin (dDAVP), has been shown to influence membrane trans...
In this paper we demonstrate, using the C7-2-HI metastatic transplantable ductal mammary tumor, that...
Histone deacetylase (HDAC) inhibitors and tumor necrosis factor–related apoptosis-inducing ligand (T...
Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis...